Cardio-Oncology and Heart Failure: a Scientific Statement From the Heart Failure Society of America

Michelle Weisfelner Bloom1, Jacqueline B Vo2, Jo E Rodgers3

  • 1Division of Cardiology, NYU Langone Health, NYU Grossman School of Medicine, New York, NY.

PubMed

Insights

Heart failure and cancer care require specialized knowledge. This statement guides healthcare professionals in managing heart failure in cancer patients, addressing cardiotoxicity and improving outcomes.

Area of Science:

  • Cardio-oncology
  • Cardiovascular Medicine
  • Oncology

Background:

  • Heart failure and cancer are leading causes of death.
  • Cancer therapies can cause cardiovascular complications.
  • Cardiomyopathy in cancer patients indicates poor prognosis.

Purpose of the Study:

  • To provide guidance on heart failure management in cancer patients.
  • To address prevention, risk stratification, diagnosis, and management of cardiotoxicity.
  • To highlight shared risk factors and multidisciplinary care.

Main Methods:

  • Review of current literature and clinical practices.
  • Development of a framework for cardio-oncology care.
  • Discussion of heart failure stages, preserved ejection fraction, and special populations.

Main Results:

  • Cancer patients face increased cardiovascular risks from therapies.
  • Heart failure is a significant cardiotoxicity associated with cancer treatments.
  • Shared risk factors between cancer and heart failure exist.

Conclusions:

  • Cardio-oncology requires a multidisciplinary approach involving heart failure, oncology, and other specialists.
  • Effective management strategies are crucial for patients with cancer and heart failure.
  • Addressing disparities in care is essential for this complex patient group.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
3
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
2
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
3
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
2
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
2